Journal article
A machine learning and directed network optimization approach to uncover TP53 regulatory patterns
- Abstract:
-
TP53, the Guardian of the Genome, is the most frequently mutated gene in human cancers and the functional characterization of its regulation is fundamental. To address this we employ two strategies: machine learning to predict the mutation status of TP53 from transcriptomic data, and directed regulatory networks to reconstruct the effect of mutations on the transcipt levels of TP53 targets. Using data from established databases (Cancer Cell Line Encyclopedia, The Cancer Genome Atlas), machine learning could predict the mutation status, but not resolve different mutations. On the contrary, directed network optimization allowed to infer the TP53 regulatory profile across: (1) mutations, (2) irradiation in lung cancer, and (3) hypoxia in breast cancer, and we could observe differential regulatory profiles dictated by (1) mutation type, (2) deleterious consequences of the mutation, (3) known hotspots, (4) protein changes, (5) stress condition (irradiation/hypoxia). This is an important first step toward using regulatory networks for the characterization of the functional consequences of mutations, and could be extended to other perturbations, with implications for drug design and precision medicine.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 6.9MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.isci.2023.108291
Authors
- Funder identifier:
- https://ror.org/054225q67
- Grant:
- 23969
- Funder identifier:
- https://ror.org/0472cxd90
- Grant:
- 772970
- Publisher:
- Cell Press
- Journal:
- iScience More from this journal
- Volume:
- 26
- Issue:
- 12
- Article number:
- 108291
- Publication date:
- 2023-10-26
- Acceptance date:
- 2023-10-18
- DOI:
- EISSN:
-
2589-0042
- Pmid:
-
38047081
- Language:
-
English
- Keywords:
- Pubs id:
-
1574757
- Local pid:
-
pubs:1574757
- Deposit date:
-
2024-10-14
Terms of use
- Copyright holder:
- Triantafyllidis et al.
- Copyright date:
- 2023
- Rights statement:
- © 2023 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record